A non-internalizing αvβ3 integrin ligand was conjugated to the anticancer drug MMAE through a β-glucuronidase-responsive linker. In the presence of β-glucuronidase, only the conjugate bearing a PEG4 spacer inhibited the proliferation of integrin-expressing cancer cells at low nanomolar concentrations, indicating important structural requirements for the efficacy of these therapeutics.
β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate / P. López Rivas, C. Müller, C. Breunig, T. Hechler, A. Pahl, D. Arosio, L. Belvisi, L. Pignataro, A. Dal Corso, C. Gennari. - In: ORGANIC & BIOMOLECULAR CHEMISTRY. - ISSN 1477-0520. - 17:19(2019 Apr 25), pp. 4705-4710.
β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate
P. López RivasPrimo
;L. Belvisi;L. Pignataro;A. Dal CorsoPenultimo
;C. Gennari
Ultimo
2019
Abstract
A non-internalizing αvβ3 integrin ligand was conjugated to the anticancer drug MMAE through a β-glucuronidase-responsive linker. In the presence of β-glucuronidase, only the conjugate bearing a PEG4 spacer inhibited the proliferation of integrin-expressing cancer cells at low nanomolar concentrations, indicating important structural requirements for the efficacy of these therapeutics.File | Dimensione | Formato | |
---|---|---|---|
Accepted manuscript_DETEMPLATED.pdf
Open Access dal 19/05/2020
Descrizione: Articolo principale
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
772.48 kB
Formato
Adobe PDF
|
772.48 kB | Adobe PDF | Visualizza/Apri |
Org. Biomol. Chem., 2019, 17, 4705–4710.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.43 MB
Formato
Adobe PDF
|
1.43 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.